Generate a tailored SOP for Dr. Liza Konnikova. Improve your application with a focused, well-structured draft.
Dr. Liza Konnikova's team focuses on the development of early life immunity, particularly at barrier sites such as the gastrointestinal tract and maternal-fetal interface, with a specific emphasis on T cell biology. Utilizing multi-omic approaches, her group investigates mucosal homeostasis and its role in the pathogenesis of various diseases, including sepsis, preterm labor, necrotizing enterocolitis (NEC), and early onset (VEO) pediatric inflammatory bowel disease (IBD). Additionally, the Konnikova lab is exploring the microbiome and associated metabolome that regulate immune development and homeostasis at barrier sites. Their research aims to understand how early life events alter circulating immune cells, contributing to health and disease. Dr. Konnikova collaborates with the NOuRISH team, enrolling infants in a longitudinal study to analyze the development of peripheral blood immune functions.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.